HOME >> MEDICINE >> NEWS
Women find physician guidelines on estrogen replacement therapy are lacking

Harvard Pilgrim Health Care's Harvard Medical School study shows women's concerns are not addressed

According to a study published in the August 17th edition of the Annals of Internal Medicine, physician guidelines are woefully inadequate in helping physicians counsel women in their decision-making process about whether to take postmenopausal estrogen replacement therapy. Based on their findings, the study's authors say that future guidelines should instruct physicians to incorporate patients' perspectives into the counseling process.

Currently, the American College of Physicians, American College of Obstetrics and Gynecology and the U.S. Preventive Services Task Force publish guidelines that recommend that caregivers counsel patients about the risks and benefits of therapy. All recommendations incorporate the best epidemiological evidence for hormone replacement therapy; however, they do not reflect the counseling needs expressed by patients.

For this study, Maureen T. Connelly, MD, and other researchers at the Department of Ambulatory Care and Prevention, a joint department of Harvard Pilgrim Health Care and Harvard Medical School, conducted indepth interviews of 26 women who had received a prescription for hormone replacement therapy. The women identified, on average, 15 factors as critical to their decision-making. The predominant influencing factors include: health care provider opinion, (96%); what media said was important, (81%); experiences and opinions of friends, (77%); and fear of breast cancer, (77%).

"Our findings support several studies that point to a substantial dissatisfaction with the decision-making process," Connelly said. "Admittedly, this is a complex issue; however, greater information about what the patient is thinking may help clinicians structure the time they spend and the materials they provide to patients. It is our hope that f
'"/>

Contact: Bill Schaller
schaller@hms.harvard.edu
617-432-0441
Harvard Medical School
17-Aug-1999


Page: 1 2

Related medicine news :

1. The European Society of Cardiology launches Women at Heart
2. Women less likely to get quality heart attack care
3. Statement on the findings of the Womens Health Study
4. Women should be advised not to drink alcohol in pregnancy
5. Women with thyroid problem have lower risk of breast cancer
6. Women successfully treated to prevent preterm labor at low risk for recurrent episode
7. Womens heart risk underestimated by doctors, resulting in less preventive care than in men
8. Women, drinking to their health
9. Women want annual pap smears
10. Women In Government report on eliminating cervical cancer
11. Women need less morphine after hysterectomies with new treatment

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/16/2017)... Grove Village, IL (PRWEB) , ... January 16, ... ... and personal audio products, will demonstrate their groundbreaking GunSport•PRO® and EB15•LE® electronic earplugs ... and Convention Center in Las Vegas, Booth #2809. The SHOT Show is the ...
(Date:1/16/2017)... ... January 16, 2017 , ... As New York’s fastest growing ... MD to their medical staff, according to eye surgeon, Jeffrey Martin, MD, FACS, ... a division of SightMD. Dr. Giamos will practice primarily out of SightMD’s Riverhead, ...
(Date:1/16/2017)... , ... January 16, 2017 , ... St. Louisans are well-aware of the following facts ... This year’s influenza shot seems to be having no effect on keeping this particularly ... half of the people around are coughing, sneezing, or sniffling , These ...
(Date:1/16/2017)... ... January 16, 2017 , ... One thing common to all types of ... test for, as well. The money spent screening for and treating cancer in the ... screen patients for cancer more than in any other country that has an advanced ...
(Date:1/15/2017)... , ... January 15, 2017 , ... In this role, ... the United States for the asthma & allergy friendly mark. This certification program was ... test and identify consumer products to be more suitable for the 60+ million people ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... , January 17, 2017 ... 1):2-4 ; http://www.touchneurology.com/articles/tailored-temperature-management-neurocritical-care ... ... recently in European Neurological Review ... Catherine Amey reports that despite standard ...
(Date:1/17/2017)... January 17, 2017 Transparency Market Research has ... Acid, Sodium Benzoate, Benzyl Alcohol and Others) Market - Global Industry ... report, the global benzaldehyde derivative market was valued at ... 2.14 Bn by 2024, expanding at a CAGR of 5.1 % ... ...
(Date:1/17/2017)... DUBLIN and BUDAPEST, Hungary , ... ) and Gedeon Richter Plc. today announced positive results from ... trials evaluating the efficacy and safety of ulipristal acetate in ... drug application filing for ulipristal acetate is planned for the ... the favorable results of Venus II supporting the efficacy and ...
Breaking Medicine Technology:
Cached News: